MolProphet

MolProphet applies artificial intelligence to accelerate early-stage small-molecule drug discovery by performing target pocket prediction, hit discovery, lead optimization, and compound targeting.

Key Features:

• AI-based target pocket prediction: Predicts ligand-binding pockets on target proteins using trained AI models.
• Hit discovery: Identifies candidate small molecules with activity against predicted target pockets.
• Lead optimization: Optimizes chemical series to improve potency and related properties using AI-driven workflows.
• Compound targeting: Maps or associates small molecules to predicted target pockets and intended targets.
• Analytical tools: Provides analytical modules to evaluate and refine prediction and optimization results.
• Drug-likeness and synthetic accessibility assessment: Evaluates drug-likeness, purchasability, and synthetic accessibility to prioritize compounds.

Scientific Applications:

• Early-stage drug discovery: Support for target identification, hit finding, and prioritization of small-molecule candidates.
• Hit-to-lead and lead optimization: Facilitation of chemical series refinement to improve efficacy-related properties.
• Small-molecule target mapping: Assignment of compounds to predicted protein pockets for structure-based design efforts.

Methodology:

Employs a series of AI models that automate target pocket prediction, hit discovery, lead optimization, and the assessment of drug-likeness, purchasability, and synthetic accessibility.